MK

Available for speaking

Matt Kaeberlein, PhD

CEO / Founder

Matt Kaeberlein, PhD is CEO / Founder. Areas of expertise include Rapamycin, aging biology, translational geroscience.

Biography

Prominent geroscientist known for rapamycin research and leadership in the Dog Aging Project.